Literature DB >> 17459274

Urologic skeletal metastases: current diagnostic and treatment strategies.

Stephanie H Alford1, Paul S Chang, Ronald P Williams.   

Abstract

Patients with skeletal metastases from all sites are increasing in number as the treatment protocols for primary tumors improve survival of patients with cancer. While diagnosis and follow-up of the patient with urologic skeletal metastasis continue to become more sophisticated with new MRI techniques and the advent of positron emission tomography, the goal of orthopedic treatment remains the same: pain relief and maintenance of mobility. This paper describes the pathogenesis of metastasis followed by strategies currently available for accurately diagnosing, treating, and following the patient with skeletal metastases secondary to urologic malignancy.

Entities:  

Mesh:

Year:  2007        PMID: 17459274     DOI: 10.1007/s11934-007-0012-x

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  20 in total

1.  Presentation and staging of metastatic bone disease.

Authors:  Bruce T Rougraff; Frank J Frassica
Journal:  Clin Orthop Relat Res       Date:  2003-10       Impact factor: 4.176

2.  THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES.

Authors:  O V Batson
Journal:  Ann Surg       Date:  1940-07       Impact factor: 12.969

Review 3.  An update on the nonoperative treatment of patients with metastatic bone disease.

Authors:  N S Schachar
Journal:  Clin Orthop Relat Res       Date:  2001-01       Impact factor: 4.176

4.  The distribution of secondary growths in cancer of the breast. 1889.

Authors:  S Paget
Journal:  Cancer Metastasis Rev       Date:  1989-08       Impact factor: 9.264

Review 5.  Ibandronate in metastatic bone pain.

Authors:  Axel Heidenreich; Carsten Ohlmann; Jean-Jacques Body
Journal:  Semin Oncol       Date:  2004-10       Impact factor: 4.929

6.  Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience.

Authors:  R Walker; P Kessar; R Blanchard; M Dimasi; K Harper; V DeCarvalho; E K Yucel; L Patriquin; S Eustace
Journal:  J Magn Reson Imaging       Date:  2000-04       Impact factor: 4.813

Review 7.  An approach to the management of the patient with metastatic bone disease.

Authors:  Kristy L Weber; Valerae O Lewis; R Lor Randall; Andrew K Lee; Dempsey Springfield
Journal:  Instr Course Lect       Date:  2004

8.  Metastatic bone disease: pathogenesis and new strategies for treatment.

Authors:  Atsumasa Uchida; Hiroki Wakabayashi; Noritaka Okuyama; Atsushi Okamura; Akihiko Matsumine; Katsuyuki Kusuzaki
Journal:  J Orthop Sci       Date:  2004       Impact factor: 1.601

9.  Epidemiology and environmental factors in urologic cancer.

Authors:  A S Morrison
Journal:  Cancer       Date:  1987-08-01       Impact factor: 6.860

10.  Fracture healing in metastatic bone disease.

Authors:  B J Gainor; P Buchert
Journal:  Clin Orthop Relat Res       Date:  1983-09       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.